The Toxicology and Immunotoxicology Unit is concerned with planning and conducting preclinical efficacy and safety studies for new drug candidates and advanced therapy medicinal products (ATMPs). These trials are carried out under GLP or GLP-analogous conditions, in accordance with the applicable guidelines. The unit’s work involves developing, establishing and validating new in-vitro and in-vivo models for inflammatory and tumorigenic diseases. Please refer to the central facility GLP Test Facility for more information.
Our focus areas